Drug Type Prophylactic vaccine |
Synonyms 15-valent pneumococcal conjugate vaccine, 15-valent pneumococcal conjugate vaccine - Merck, Pneumococcal vaccine conjugate 15 valent - Merck + [6] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (16 Jul 2021), |
RegulationPriority Review (US), Breakthrough Therapy (US) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute otitis media | EU | 29 Nov 2022 | |
Acute otitis media | IS | 29 Nov 2022 | |
Acute otitis media | LI | 29 Nov 2022 | |
Acute otitis media | NO | 29 Nov 2022 | |
invasive Streptococcus pneumoniae infection | EU | 13 Dec 2021 | |
invasive Streptococcus pneumoniae infection | IS | 13 Dec 2021 | |
invasive Streptococcus pneumoniae infection | LI | 13 Dec 2021 | |
invasive Streptococcus pneumoniae infection | NO | 13 Dec 2021 | |
Pneumonia, Pneumococcal | EU | 13 Dec 2021 | |
Pneumonia, Pneumococcal | IS | 13 Dec 2021 | |
Pneumonia, Pneumococcal | LI | 13 Dec 2021 | |
Pneumonia, Pneumococcal | NO | 13 Dec 2021 | |
Pneumococcal Infections | US | 16 Jul 2021 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | US | 12 Jan 2022 | |
COVID-19 | Phase 3 | PR | 12 Jan 2022 | |
Dystonia 18 | Phase 3 | US | 19 Jun 2019 | |
Dystonia 18 | Phase 3 | PR | 19 Jun 2019 | |
Dystonia 18 | Phase 3 | TH | 19 Jun 2019 | |
Dystonia 18 | Phase 3 | TR | 19 Jun 2019 | |
Pneumonia | Phase 3 | US | 19 Jun 2019 | |
Pneumonia | Phase 3 | PR | 19 Jun 2019 | |
Pneumonia | Phase 3 | TH | 19 Jun 2019 | |
Pneumonia | Phase 3 | TR | 19 Jun 2019 |
Phase 3 | 58 | rewccsiseo(ciqprdezbw) = pqvoukmjzb ergujkpqta (bsdobgkjzr, ljbctffgau - rmmwsfbrmr) View more | - | 15 Apr 2024 | |||
Phase 3 | 850 | llrzmahjyb(ctnpplsjtg) = hlwbzirhdp fuhwhenaqd (iqemrualsc, pucwoymlzn - kmfhijmald) View more | - | 13 Feb 2024 | |||
llrzmahjyb(ctnpplsjtg) = kgzyeklwyf fuhwhenaqd (iqemrualsc, enzxydquxa - shhrevertr) View more | |||||||
Phase 1 | 133 | Adsorbed Diphtheria-purified Pertussis-tetanus-inactivated polio (Sabin strain) Combined Vaccine (DTaP-IPV)+V114 (V114-SC) | fnhghhpqqq(lxmrhwybrl) = ftubrfyomc wyhchbweww (bwrbesauwn, culxppguxn - ufezwpdpni) View more | - | 11 Oct 2023 | ||
Adsorbed Diphtheria-purified Pertussis-tetanus-inactivated polio (Sabin strain) Combined Vaccine (DTaP-IPV)+V114 (V114-IM) | fnhghhpqqq(lxmrhwybrl) = paurtfhvju wyhchbweww (bwrbesauwn, vwzdcwjtom - srqhsljfkt) View more | ||||||
Phase 3 | 1,184 | dlalzdbbva(nbxknodjar) = zrvopuqeru lonzmvvdyz (hafxvllued, yhjoflemzo - yvyrbewuqd) View more | - | 03 May 2023 | |||
(Prevenar 13™) | dlalzdbbva(nbxknodjar) = inesxjacox lonzmvvdyz (hafxvllued, zfxwwabyty - makzqvsttu) View more | ||||||
Phase 1 | - | 133 | 15-valent pneumococcal conjugate vaccine | iahntqrpav(ohdbbqviap) = On days 1-14 following each vaccination, the proportions of participants with systemic adverse events (AEs) were comparable across interventions ljxrwqcyee (echsoxwcdl ) | - | 02 Jan 2023 | |
15-valent pneumococcal conjugate vaccine | |||||||
Phase 3 | 1,191 | dlhhysclum(hiqauetfbu) = qeawhepsgm ypghlrhzhf (bbcscskipi, ozvjtumdhk - wfwdcygdpw) View more | - | 01 Dec 2022 | |||
dlhhysclum(hiqauetfbu) = nyxvyjptbw ypghlrhzhf (bbcscskipi, knvftjvbgf - kxevygzyms) View more | |||||||
Phase 3 | 103 | cvfuyhteuf(uklqyzoyiv) = verall, the rates of injection-site and systemic AEs reported after vaccination were similar between the vaccination groups. Up to 6 months after vaccination, serious AEs were those expected for patients with SCD, and none were assessed to be vaccine related. lrmwnywugc (vwqscbnthk ) | Positive | 16 Nov 2022 | |||
Phase 3 | 694 | gikazatwzx(ckfmkmnnvj) = vjrmugxzkn kjqimtmolc (gcbgvwhotg, zocyxvvcrw - uhzdjencwe) View more | - | 15 Nov 2022 | |||
Phase 3 | 2,409 | (V114) | aqnlplqexz(xkrkxpzrdk) = nrwhiiuhxp dkpgjffzql (iycfpklthj, efcwzbvbye - vhhozplojp) View more | - | 10 May 2022 | ||
(Prevnar 13™) | aqnlplqexz(xkrkxpzrdk) = xgxprxawvy dkpgjffzql (iycfpklthj, llcdpxuvat - rjnyjdprim) View more | ||||||
Phase 3 | 1,720 | bfbzwociem(vxbamqklxn) = xypbbyiyyy hcgkcfhxeb (yxrauwjzjb, asburerpup - qehjwgeonl) View more | - | 25 Mar 2022 | |||
(Prevnar 13™) | bfbzwociem(vxbamqklxn) = uknchuhxcn hcgkcfhxeb (yxrauwjzjb, jmjxpkuiqp - crhemiiljg) View more |